Quality of Care Reigns Supreme: Cardiologists at the Helm  by Wolk, Michael J.
PQ
C
M
I
W
I
t
s
h
d
W
i
d
p
d
p
p
d
o
c
c
h
i
m
s
W
o
t
c
h
e
a
b
d
s
A
w
e
e
i
d
d
S
Journal of the American College of Cardiology Vol. 45, No. 12, 2005
© 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00
PLENARY ADDRESS
uality of Care Reigns Supreme:
ardiologists at the Helm
ichael J. Wolk, MD, MACC
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.005mmediate Past President, American College of Cardiology
f
p
c
a
d
“
w
c
m
s
m
w
o
t
o
a
m
T
t
s
a
o
a
o
b
t
t
w
s
t
d
b
p
ie have come to a curious crossroads in cardiovascular care.
n our pioneering days, we begged for the simplest of tools
o do our daily work. Today, with all the marvels of medical
cience at our fingertips, we are blessed with an arsenal of
igh-tech weapons and therapeutic agents to combat heart
isease.
We can see the heart beating, even in three dimensions.
e can define the adequacy of coronary perfusion and
nflammation within a vessel wall. We can track heart
isease at every stage, a visual we could only imagine in the
ast. We have drug-eluting stents, implantable cardioverter-
efibrillators, left ventricular assist devices, echocardiogra-
hy, computed tomography, magnetic resonance, and
ositron emission tomography that define innovation, and
rugs like statins have introduced the word “reversal” into
ur everyday vocabulary.
Yet, all this sci-fi ability presents us with the unique
hallenge and frustration of determining appropriate appli-
ation and equitable allocation. This is a great problem to
ave: people are living longer and quality of life is dramat-
cally improving.
But as cardiologists using this fabulous technology, we
ust confront difficult and complex questions: When
hould these tests be performed—or not be performed?
ho should do these tests? Which location—hospital or
ffice—is best? Who should pay? Can our global society
ruly afford the remarkable quality of life we are rapidly
reating for our patients?
Historically, ideal cardiovascular care was solely in the
ead of each provider. Best practice based on aggregated
vidence was a dream. But today, as we strive for value-
dded quality care, we actively seek practical, evidence-
ased patient care protocols that capitalize on our collective
ata. We believe we can learn from each other without
tumbling through the rocks by ourselves.
The American College of Cardiology (ACC) and the
merican Heart Association (AHA), often in partnership
ith others, have translated scientific advances into 17
vidence-based clinical guidelines covering topics from isch-
mic heart disease to heart failure. These pragmatic tools
mprove patient care outcomes by narrowing the wide and
eep gulf currently separating evidence from practice. In-
eed, this critical theme undergirds the ACC’s 54th Annual
cientific Session. iEvidence-based medicine has arrived just in time. We are
acing a global pandemic of heart disease, and we need to be
repared. In 2002, cardiovascular disease in the U.S. ac-
ounted for 6.5 million hospitalizations and nearly 40% of
ll deaths, with more women than men dying from heart
isease (1).
The ticking time bomb of our aging population and the
perfect storm” of diabetes and obesity may shortly over-
helm our ability to provide cost-effective cardiovascular
are.
In view of limited resources for our larger global com-
unity, it is essential that we embrace our guidelines as we
hift our paradigm from intervention to prevention. We
ust resolutely protect our patients who are still healthy,
hile treating our patients whose heart disease is rampant.
One immutable fact remains, however. Guidelines are
nly as good as the research on which they are based, and
hey are only useful to the extent we use them. Sadly, reality
ften does not meet our expectation.
Physicians, and their cardiac care teams worldwide, report
lack of guideline awareness or even apathy as they try to
anage fast-paced and highly pressured everyday practices.
his dramatic “voltage drop” from discovery-to-guidelines-
o-application is real for patients. Many studies show a
trong relationship between use of evidence-based treatment
nd positive patient outcomes.
For example, despite what each of us understands as
ptimal treatment following an acute myocardial infarction,
national health care quality report suggests more than 20%
f patients still do not receive essential medication (2).
The simplest and cheapest treatments, such as aspirin,
eta-blockers, and angiotensin-converting enzyme inhibi-
ors, each of which could decrease risk of death by one-
hird, are often overlooked by us and by the hospitals in
hich we work.
My colleague on our board of trustees, Robb Califf, when
peaking about the reaction of doctors faced with data about
heir own practices, stated: “First, you’re in shock, then
enial, then you gradually come to terms with what needs to
e done.”
Hospitals that improved in these particular measures saw
atient mortality from all causes decline by 40%. Using
ncentives like bonus pay and deterrents like public humil-
ation, Medicare is strongly encouraging hospitals and
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ommon ailments (2).
Although underutilization of evidence-based therapy is a
ignificant concern, we cardiologists can quickly learn which
herapies were omitted and why, and we can begin to
odify our patterns of care.
By contrast, we are more defensive about charges of
veruse or misuse of services. We complain about allega-
ions that we might order unwarranted tests and therapies,
specially when promoted by payers or the press, or by
elf-interested competing specialties of medicine.
In 1973, Jack Wennberg published a landmark study in
cience documenting distinctive, geographic variations in
linical practice patterns in the U.S. (3). Thirty years later,
sing imaging as the example, Wennberg now reports a
hree-fold variation in use of this modality across the
ountry. He recently observed that such variations in care
atterns cannot be easily explained by “illness, patient
reference, or the dictates of evidence-based medicine” (4).
Likewise, two recent Dartmouth studies published in the
ournal Health Affairs suggested an inverse relationship
etween utilization of health care testing and health care
uality (4). Data also link states with higher Medicare
pending to lower quality of care. Clearly a puzzling case of
ore is less.
These observations are instigating attempts by the federal
overnment and by health plans to “manage” this variability
y funding pilot demonstration projects in disease manage-
ent, pay for-performance models, tiered provider net-
orks, pre-certification of tests, and limitations on autho-
ized imagers. These are real-life and compelling reasons we
hould immediately incorporate our guidelines, performance
easures, and appropriateness criteria into daily practice.
In addition, we must actively counter a serious threat by
he radiology leadership, who are directly challenging our
bility to use the best and latest technology to care for our
atients in our offices and in the hospitals in which we work.
ur rights—and more important, the rights of our pa-
ients—are in danger of being permanently abridged.
This struggle involves not only us as cardiologists, but our
ntire physician family of orthopedists, obstetricians, urol-
gists, gastroenterologists, internists, and so on. Radiology
pokesmen are systematically and unfairly distorting studies.
heir data intentionally malign “non-radiologist” use of
maging technology and insinuate self-motivated imaging
eferrals that result in overutilization for profit. We cate-
orically deny any collective attempt to inappropriately
rofit from imaging, but some of their critique deserves
crutiny.
For example, their leadership publicly points to statistics
rom 2003 showing in-office nuclear imaging growing 30%
n 1 year, and more than 1 in 4 Medicare beneficiaries
btaining a cardiac imaging test annually. Expansion of
any cardiovascular services, including imaging, is clearly a
ecurring theme in the communities in which we work. tHowever, we believe the significant growth in imaging
hould have been anticipated by the major payers. Driven by
he relentless triad of more effective diagnosis and earlier
reatment, demographics, and disease-state management,
maging volumes have naturally exploded and transferred
ite of delivery from hospital to office.
So far, the ACC has successfully staved off federal
overnmental action against in-office testing, but there is
rouble brewing among health plans and Medicare. Insurers
ave emerged as radiology’s unexpected allies by demanding
tricter privileging requirements based on American College
f Radiology (ACR)-supplied criteria. They may force strict
nd mandatory ACR accreditation of laboratories, as well as
re-certification of cardiovascular procedures by the radiol-
gist vendor industry.
The ACC strongly supports imaging quality measures
nd credentialing, but not by pitting one physician group
gainst another. All qualified physicians must be permitted
o use essential tools to do their job. In today’s world, that
eans wisely integrating imaging technology into office
ractices. We must carefully and accountably incorporate
ew technologies in patient care plans only after thoroughly
xamining their effectiveness.
Beyond these efforts to ensure effective care, the ethics of
are remain paramount. The 2004 Consensus Conference
n Professionalism and Ethics produced a detailed report,
ublished in the Journal of the American College of Cardiology
nd in Circulation, that covered “appropriate self-referral”
5). We determined that the most essential need for the
CC and its members is to fast track appropriateness
riteria for imaging. Appropriateness will be the college’s
nest effort to define “what to do,” “when to do,” and “how
ften to do” in the context of local care environments when
ombined with patient and family preferences.
Ideally, appropriateness criteria would encompass “cost
ffective” and “benefit versus risk” analysis of available
reatment alternatives. These should be simple, reliable,
alid, and transparent. They should provide cardiovascular
pecialists with meaningful feedback on their care practices
elative to national standards.
Answers to the appropriate use of imaging will require
hat we dedicate ourselves to the same type of rigorous
linical research that has made cardiovascular medicine the
nvy of health care. We need to be as confident about our
se of imaging tests as we are about the treatment of
oronary artery disease or congestive heart failure.
Some may not appreciate the critical nature of the ACC’s
fforts to address appropriateness. Some will argue explicit
uideline performance indicators can be divisive in challeng-
ng judgment. Others may argue this is “cookbook” medi-
ine and beneath our dignity. I argue that the ACC must
ackle these tough topics head-on, and if we do not lead in
his effort, others will. And they will undoubtedly emphasize
ost control and not quality improvement. It is the perfect
ime for us, as cardiologists, to quantify quality.
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are stewardship? The ACC will:
Create, with the AHA, for the 25th year, outstanding
clinical practice guidelines that spearhead appropriate-
ness criteria for nuclear imaging, as a prototype for all
imaging
Proactively embed guidelines into electronic medical
records
Develop specific systems and tools, such as pre-printed
admission and discharge planning materials, to improve
on-site delivery of care
Expand respected national catheterization laboratory
registries that measure and provide feedback on perfor-
mance for individual practices and hospitals
Work directly with health plan medical directors to
ensure quality is not divorced from payment.
As Antoine de Saint-Exupery said in Wind, Sand, and
tars, “it is the duty of the ship’s captain to make port, cost
hat it may” (6). Our goal as a college is to grab the helm
ith both hands. The ACC will author and adopt the very
est evidence-based guidelines and quality indicators to
upport you in your daily practice. We have a moral and
rofessional obligation to take up this manifest, and we
ccept this responsibility with enthusiasm and conviction.
In this remarkable environment in which we are privi-eged to work, we must be good stewards of the gifts andesponsibilities that have been entrusted to us. I ask each of
ou to join in this effort through your local ACC chapter.
We will not shirk our duty, and we will not run and hide.
e will stand firm and make our voices heard; here in
rlando, at home in our offices, and on Capitol Hill in
ashington.
I look forward to working with each of you in this effort.
end correspondence to: Dr. Michael J. Wolk, 520 East 72nd
treet, New York, New York 10021.
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